Anti-HSP90 alpha antibody and uses thereof

BROADLY NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES TARGETING THE N-TERMINAL DOMAIN OF THE SPIKE PROTEIN AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE

PROTEIN TYROSINE KINASE 7 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

Nucleic acid scaffolded artificial immune complexes

MONOCLONAL ANTIBODIES TARGETING CONFORMATION-SPECIFIC EPITOPES OF IMMUNOGLOBULIN LIGHT CHAINS OF THE LAMBDA SUBCLASS

METHOD AND MEANS FOR ENHANCING THERAPEUTIC ANTIBODIES

ANTI-CD3 ANTIBODIES AND METHODS OF USE THEREOF

5T4 BINDING AGENTS AND USES THEREOF

HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF

ANTI-PDL1 ANTIBODIES, MULTISPECIFIC ANTIBODIES AND METHODS OF USE

SINGLE-DOMAIN ANTIBODY TARGETING PD-1, DERIVATIVE THEREOF AND USE THEREOF

T CELL RECEPTOR MULTIMERS AND USES THEREOF

ANTI-PVRIG ANTIBODIES AND METHODS OF USE

ANTIBODIES AGAINST TIM3 AND USES THEREOF

BISPECIFIC ANTIBODY TARGETING SIRP-alpha AND PD-L1 OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE

ANTI-SIGLEC15 ANTIBODY AND USE THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

ANTIBODY THAT BINDS TO CANNABINOID TYPE 1 RECEPTORS

IL31-BINDING POLYPEPTIDES AND USES THEREOF

ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Antibodies Specifically Recognizing Gdf15 and Uses Thereof

IMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES

BINDING AGENTS CAPABLE OF BINDING TO CD27 IN COMBINATION THERAPY

BISPECIFIC ANTIGEN BINDING PROTEIN

ANTI-4-1BB NANOBODIES

COMPOSITIONS COMPRISING ENHANCED MULTISPECIFIC BINDING AGENTS FOR AN IMMUNE RESPONSE

ANTI-TNFR2 ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF

INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

BISPECIFIC DENDRITIC CELL ENGAGER AND USES THEREOF

ANTI-PDL1 ANTIBODIES AND METHODS OF USE

CD8-Binding Polypeptides and Uses Thereof

BISPECIFIC ANTIBODY FOR T-CELL MODULATION

KIDNEY-GLOMERULAR TARGETED IMMUNOTHERAPY

ANTIBODIES TO PYROGLUTAMATE AMYLOID-B AND USES THEREOF

ALBUMIN BINDING PROTEINS AND METHODS OF USE

Antibodies Binding to Alpha-Synuclein for Therapy and Diagnosis

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

BROADLY NEUTRALIZING ANTIBODIES THAT TARGET HIV ENV V3 N-GLYCANS

CHIMERIC ANTI-SARS-COV2 NUCLEOPROTEIN ANTIBODIES

ANTIBODIES OR ANTIBODY-FRAGMENTS THEREOF TARGETING ALPHAVIRUSES, AND COMPOSITIONS AND METHODS COMPRISING SAME

ANTI-LY6H ANTIBODIES AND ANTIBODY DRUG CONJUGATES

FUSION PROTEIN CONTAINING ANTI-TIGIT ANTIBODY AND TGF-ßR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

POLYPEPTIDES

GLYCOENGINEERED ANTIBODIES

CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF

ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TL1A AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

ALPHA4BETA7 INTEGRIN BINDING PROTEINS AND METHODS OF USE

ANTI-INTEGRIN ANTIBODIES AND USES THEREOF

NOVEL ANTI-PD-L1 ANTIBODIES

Anti-B7H3 antibody and Uses thereof

ANTI-B7-H3 ANTIBODIES AND USES THEREOF

PH-SELECTIVE ANTI-CD3 ANTIBODIES AND USE OF THE SAME

BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD19 AND CD3, AND USES THEREOF

NOVEL ANTI-LAG3 ANTIBODIES

ANTI-PAR2 ANTIBODIES

NOVEL CYTOKINE-BASED THERAPIES AND METHODS

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

SARBECOVIRUS SPIKE S2 SUBUNIT BINDERS

BIVALENT, BISPECIFIC BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION

ANTI-PROTAC ANTIBODIES AND COMPLEXES

ANTIBODY TARGETING CCR8 AND ITS APPLICATIONS

ANTIBODY TARGETING CLAUDIN18.2 AND ITS APPLICATIONS

FUSION PROTEIN OF RELAXIN OR ANALOGUE AND MEDICAL USE THEREOF

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

ANTI-GLYCO-MUC1 ANTIBODIES AND THEIR USES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MUSCULAR DYSTROPHY

MULTISPECIFIC BINDING MOLECULES AND METHODS OF USE THEREOF

MONOCLONAL ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF THAT SPECIFICALLY BINDS TO BCMA, AND USE THEREOF

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

ANTI-HUMAN IL-4RA ANTIBODY AND APPLICATION THEREOF

WNT SIGNALING AGONIST MOLECULES

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

ANTI-HLA-DQ2.5 ANTIBODY

THERAPEUTIC AGENT COMPRISING MULTISPECIFIC ANTIBODY AND USE THEREOF IN TUMOR THERAPY

CONDITIONALLY BISPECIFIC BINDING PROTEINS

ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE

ANTI-RAGE ANTIBODY, EXTRACELLULAR VESICLE, AND PREPARATION METHOD AND USE THEREOF

Blood-Cerebrospinal Fluid Barrier Crossing Antibodies

ANTIBODIES TO AMYLOID BETA

RGMC-SELECTIVE INHIBITORS AND USE THEREOF

Cardiac troponin I specific antibody, kit and uses thereof

VHH ANTIBODIES TARGETING FIMH AND METHODS OF USING THE SAME

ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODY FOR MEMBRANE CLEARANCE OF TARGET RECEPTORS

HUMAN ANTIBODIES AGAINST FAP-ALPHA

HUMAN FC VARIANTS HAVING IMPROVED FCGRIIA BINDING SELECTIVITY

ANTI-MUC17 NANOBODY AND USE THEREOF

ANTI-GPC3 CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF

ANTIBODIES TO CANCER GLYCOSYLATION AND USES THEREOF

THERAPEUTIC ANTIBODIES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

BCMA ANTIBODY AND USE THEREOF

RANK-L BINDING MOLECULES

IL-18BP ANTAGONIST ANTIBODIES AND THEIR USE IN MONOTHERAPY AND COMBINATION THERAPY IN THE TREATMENT OF CANCER

ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF

HLA-G-SPECIFIC ANTIBODY AND USE THEREOF

Anti-B7-H4 Antibodies and Immunoconjugates

ANTI-PD-1 MONOCLONAL ANTIBODY, DERIVATIVE THEREOF AND USE THEREOF

MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF

PREPARATIONS CONTAINING ANTI-CLAUDIN18.2/CD3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF

NECTIN-4 BINDING AGENTS

BISPECIFIC T-CELL ENGAGER, RECOMBINANT ONCOLYTIC VIRUS THEREOF, AND USE THEREOF

COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

ANGIOPOIETIN-RELATED PROTEIN 7-SPECIFIC ANTIBODIES AND USES THEREOF

ANTIGEN BINDING PROTEIN AND USES THEREOF

SLITRK6 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

PRECISION ACTIVATED POLYPEPTIDES

ANTIBODIES AND THERAPEUTIC USES THEREOF

ENGINEERED POLYPEPTIDES

POTENTLY NEUTRALIZING NOVEL HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 (COVID-19)

THERAPEUTIC AND DIAGNOSTIC AGENTS AND USES THEREOF

ENGINEERED POLYPEPTIDES AND USES THEREOF

5T4 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

CD25 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF

MODULAR SELF ASSEMBLY DISASSEMBLY (SADA) TECHNOLOGIES

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

ANTI-CD3E/BCMA BISPECIFIC ANTIBODY AND USE THEREOF

HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS

ANTI-CCR8 ANTIBODIES AND USES THEREOF

INTEGRIN ALPHA-7 BETA-1 ANTIBODIES AND USES THEREOF

ACTIVATABLE MASKED ANTI-CTLA4 BINDING PROTEINS

ANTI-CD300C ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USES THEREOF FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE

ENGINEERED PROTEASE ACTIVITY RESPONSIVE RECEPTORS AND USES THEREOF

ANTI-NOTCH3 ANTIBODIES

NOVEL ANTIGEN BINDING MOLECULE FORMATS

Antibodies to Amyloid Beta

COMPLEMENT FACTOR H RELATED 4-SPECIFIC ANTIBODIES AND USES THEREOF

SARS-COV-2 ANTIBODIES AND METHODS OF USING THE SAME

VECTORIZED ANTI-TNF-ALPHA INHIBITORS FOR OCULAR INDICATIONS

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bind PSMA and CD3, and Uses Thereof

HUMANIZED ANTI-PSMA ANTIBODY

BISPECIFIC ANTIBODY

ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS

ANTIBODIES AND BISPECIFIC BINDING PROTEINS THAT BIND OX40 AND/OR PD-L1

ANTIBODY VARIABLE DOMAINS THAT BIND IL-4R

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR IL-4R AND IL-31

COMPOSITIONS AND METHODS FOR MODULATING ANTIGEN BINDING ACTIVITY

STABLE Fc FRAGMENTS, CONJUGATES, COMPOSITIONS, AND METHODS OF USE

B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME

HETEROMULTIMER BINDING DLL3 AND CD3

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

ZIP12 ANTIBODY

INHIBITORS OF COMPLEMENT FACTOR H

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA)

Monoclonal Antibody A38 Against Rift Valley Fever Virus and Use

STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF

CD4-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS AND USES THEREOF

ANTIBODY USED TO TREAT CORONAVIRUS INFECTION

ANTIBODIES THAT BIND GLUCOSAMINIDASE AND USES THEREOF

MONOCLONAL ANTIBODY AGAINST HUMAN ACTIVATED PROTEIN C AND PREPARATION AND USE THEREOF

BI- OR MULTI-SPECIFIC ANTIBODY

PSMA ANTIBODIES AND USES THEREOF

ANTIBODIES THAT BIND TNFRSF25

DEVELOPMENT AND APPLICATION OF T-CELL ENGAGER THERAPEUTIC AGENT

POLYNUCLEOTIDES ENCODING, AND METHOD OF MAKING, A POLYPEPTIDE COMPRISING A VHH WHICH BINDS INTERLEUKIN- RECEPTOR (IL-7R)

ANTI-FGFR2 ADCC ENHANCED ANTIBODY AND USE THEREOF

AGENT, USES AND METHODS FOR TREATMENT

CANINE PD-L1 ANTIBODY, ANTIGEN BINDING FRAGMENTS THEREOF, AND METHODS OF USE THEREOF

ANTI-PD-L1 ANTIBODY AND USE THEREOF

ANTIBODIES SPECIFIC TO PD-1 AND METHODS OF USE

ANTI-CD8 ALPHA DEPLETING ANTIBODIES

Caninized Antibodies

TIM-3-TARGETING ANTIBODIES AND USES THEREOF

ANTIBODY SPECIFICALLY BINDING TO CD47 AND ANTIGEN-BINDING FRAGMENT THEREOF

ANTI-NAPI2B ANTIBODIES AND METHODS OF USE

CANNABINOID TYPE 1 RECEPTOR BINDING PROTEINS AND USES THEREOF

ANTIBODY OR ANTIBODY FRAGMENT THAT SPECIFICALLY BINDS TO VOLTAGE-GATED SODIUM CHANNEL ALPHA SUBUNIT NAV1.7

ANTIBODIES AGAINST CLAUDIN-6 AND USES THEREOF

Monoclonal Antibodies Against CLDN18.2 and Fc-Engineered Versions Thereof

MOLECULES WITH MULTIPLE BINDING DOMAINS

MULTIFUNCTIONAL BISPECIFIC FUSION POLYPEPTIDE

ANTIBODIES SPECIFICALLY RECOGNIZING THYMIC STROMAL LYMPHOPOIETIN AND USES THEREOF

Methods for Preventing and Treating Cardiac Dysfunction and COVID-19 with Activin A Antagonists

ANTIBODIES TO CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND USES THEREOF

ANTI-GDF-15 ANTIBODIES

Albumin-Binding Polypeptides and Uses Thereof

ANTIBODIES AND METHODS OF USE

METHODS AND COMPOSITIONS FOR RE-DOSING AAV USING ANTI-CD40 ANTAGONISTIC ANTIBODY TO SUPPRESS HOST ANTI-AAV ANTIBODY RESPONSE

A GROUP OF B7H3 MONOCLONAL ANTIBODIES AND MEDICAL USE THEREOF

GLUCAGON RECEPTOR AGONISTS AND CONJUGATES TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANTAGONISTS

RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2

Antibodies That Bind GLP1R

ANTI-GPNMB ANTIBODIES AND METHODS OF USE THEREOF

CD98HC ANTIGEN-BINDING DOMAINS AND USES THEREFOR

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

TRANSFERRIN RECEPTOR ANTIGEN-BINDING DOMAINS AND USES THEREFOR

ANTI-BCMA HEAVY CHAIN-ONLY ANTIBODIES

ALK2 ANTIBODIES AND METHODS OF USE THEREOF

TGF-BETA-RII BINDING PROTEINS

KLRB1 BINDING AGENTS AND METHODS OF USE THEREOF

SPECIFIC BINDING MOLECULES

STABILIZED IGG4 ANTIBODIES AND USES THEREOF

HHLA2 BINDING AGENTS WITH NOVEL ACTIVITY

ANTI-PD-1 ANTIBODY AND USES THEREOF

ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF

NOVEL ANTI-SIRPA ANTIBODIES

MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF

ANTIBODIES AND METHODS TARGETING INTERLEUKIN-19

ANTIBODY EPITOPE

ANTIBODIES AND USES THEREOF

ANTI-ABETA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF

ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS SPECIFICALLY BINDING TO GREMLIN-1 AND USES THEREOF

TAU BINDING MOLECULES

ANTIBODY MOLECULES AND USES THEREOF

ROR1-SPECIFIC VARIANT ANTIGEN BINDING MOLECULES

ANTI-HUMAN B7-H3 ANTIBODY AND APPLICATION THEREOF

TARGETING MODULES AGAINST CD123 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR-MEDIATED IMMUNE RESPONSE IN A MAMMAL

Afucosylated Anti-FGFR2IIIB Antibodies

Treatment and Prophylaxis of Amyloidosis

IMMUNE CELL INHIBITION BY IMMUNE CHECKPOINT ENGAGERS

MULTI-DOMAIN PROTEINS WITH INCREASED NATIVE STATE COLLOIDAL STABILITY

System and Method for Improved Transient Protein Expression in CHO Cells

ANTIBODY AGAINST KYNURENINE

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

Anti-CD98hc VNARs for Crossing the Blood Brain Barrier and Type IV VNAR Libraries

ANTI-CD24 ANTIBODY AND USE THEREOF

ANTIBODIES, USES & METHODS

Cation-Independent Mannose-6-Phosphate Receptor Binders

ANTI-IGF-1 RECEPTOR HUMANIZED ANTIBODY

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

Monoclonal Antibodies Against CLDN18.2 and Fc-Engineered Versions Thereof

Monoclonal Antibodies Against CLDN18.2 and FC-Engineered Versions Thereof

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF

TREATING REFRACTORY MIGRAINE

COMPOSITIONS AND METHODS FOR TREATING AND SUPPRESSING ALLERGIC RESPONSES

NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF

POLYPEPTIDES TARGETING SARS-COV-2 AND RELATED COMPOSITIONS AND METHODS

BINDING MOLECULE HAVING NEUTRALIZING ACTIVITY AGAINST CORONAVIRUS SUPERFAMILY

BIFUNCTIONAL MOLECULE FORMED BY FUSION OF PD1 ANTIBODY AND INTERLEUKIN 2

GLYCOPROTEIN HAVING REDUCED NUMBER OF MANNOSE-6-PHOSPHATES

ANTI-MUC1 ANTIBODY

ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents

ANTI-TROP2 ANTIBODY-DRUG CONJUGATE

ADAMTS Binding Immunoglobulins

ANTI-CD122 ANTIBODIES AND USES THEREOF

ANTI-IL-31RA ANTIBODIES AND USES THEREOF

FUSION PROTEIN PLATFORM HAVING IMPROVED HALF-LIFE

Anti-CD28 Antibodies and Methods of Use Thereof

ANTI-Vbeta17/ANTI-CD123 BISPECIFIC ANTIBODIES

ANTI-ROR1 ANTIBODIES

Anti-CD47/Anti-CLDN18.2 Bispecific Antibody and Use Thereof

Anti-DLL3 Antibodies and Uses Thereof

THERAPEUTIC ANTIBODIES

ANTIBODIES SPECIFIC FOR HYPERPHOSPHORYLATED TAU AND METHODS OF USE THEREOF

ANTI-CD70 NANOANTIBODY AND USE THEREOF

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE ANTIBODIES AND USES THEREOF

DEGRADATION OF SURFACE PROTEINS USING DUAL BINDING AGENT

ANTI-MSLN ANTIBODY AND APPLICATION THEREOF

CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF

ANTIBODIES TARGETING SIRP-ALPHA AND USES THEREOF

BISPECIFIC ANTIBODY BINDING TO TfR

ANTIBODIES THAT BIND TO OX40 AND THEIR USES

USES OF PDL1-BINDING PROTEINS

ANTI-C-C MOTIF CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES AND METHODS OF USE

SIL-6R AND CTGF BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF

CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF

ANTIBODIES TARGETING EGFR AND CD3 AND USES THEREOF

NOVEL LILRB4 ANTIBODIES AND USES THEREOF

ANTIBODY AGAINST CEACAM5 AND CEACAM6, AND USE THEREOF

PROTEINS THAT BIND FOLATE RECEPTOR ALPHA INCLUDING FULLY-HUMAN ANTIBODIES

ANTI-AGE ANTIBODIES FOR TREATING NEURODEGENERATIVE DISORDERS

ANG-2/VEGF ANTIBODIES AND USES THEREOF

MASKED IL-2 CYTOKINES AND METHODS OF USE THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

COMBINATION THERAPY FOR TREATING TUMOR ANTIGEN EXPRESSING CANCERS

CYTOKINE ENGAGERS AND USES THEREOF

CELLS EXPRESSING ANTI-CD70 CHIMERIC RECEPTOR AND USES THEREOF

PRAME IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING PRAME IMMUNOGENIC PEPTIDES, AND USES THEREOF

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST OPIOIDS

AGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR 2 ANTIBODIES

METHODS OF TREATING INFLAMMATORY DISEASES WITH COMBINATION OF TL1A INHIBITORS AND IL23 INHIBITORS

ANTI-CCR8 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF

CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF

ANTI-B7H3 ANTIBODIES AND METHODS OF USE

PD-L1 BINDING AFFIMERS

MULTI-DOMAIN BINDING MOLECULES

HUMANIZED ANTI-BASIGIN ANTIBODIES AND THE USE THEREOF

ENGINEERED ANTI-IL-2 ANTIBODIES

ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

Anti-Polyubiquitin Antibodies

TAU BINDING COMPOUNDS

COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

ANTIBODY COMPOSITIONS AND OPTIMIZATION METHODS

ANTIBODIES, ANTIBODY-DRUG CONJUGATES, PREPARATIONS AND USES THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY

RABBIT ANTIBODIES TO HUMAN IMMUNOGLOBULINS G

METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT DISCOVERY OF PEPTIDE-MHC TARGETING BINDING PROTEINS

COMPOSITION AND METHOD FOR INHIBITING FIBROSIS

ANTIGEN-BINDING PROTEIN COMPRISING TWO FC DOMAINS AND USE THEREOF